HER2 and proliferation of wound-induced breast carcinoma
Date
2003-11-01
Authors
Tez, M.
Göçmen, E.
Özçelik, T.
Editor(s)
Advisor
Supervisor
Co-Advisor
Co-Supervisor
Instructor
Source Title
The Lancet
Print ISSN
0140-6736
Electronic ISSN
Publisher
The Lancet Publishing
Volume
362
Issue
9394
Pages
1503 - 1503
Language
English
Type
Journal Title
Journal ISSN
Volume Title
Series
Abstract
Course
Other identifiers
Book Title
Keywords
Angiopoietin , Transforming growth factor beta , Trastuzumab , Vasculotropin , Epidermal Growth Factor Receptor 2 , Interstitial Collagenase , Monoclonal Antibody , Vasculotropin A , Angiogenesis , Antigen Expression , Breast Carcinoma , Cancer Surgery , Carcinoma Cell , Cell Proliferation , Gene Overexpression , Growth Stimulation , Human , Letter , Metastasis , Physiology , Priority Journal , Tumor , Tumor growth , Wound , Breast tumor , Cell division , Female , Gene expression regulation , Genetics , Note , Pathophysiology , Proto oncogene , Structure activity relation , Carcinoma in situ , Drug antagonism , Neovascularization (pathology) , Breast neoplasms , Cell division , Female , Gene expression regulation , Neoplastic , Genes , Erbb-2 , Humans , Matrix metalloproteinase 1 , Receptor , Erbb-2 , Structure-activity relationship , Antibodies , Monoclonal , Breast neoplasms , Carcinoma in situ , Neovascularization , Pathologic , Vascular endothelial growth factor A